nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—MUT—hair follicle—skin cancer	0.0169	0.0586	CbGeAlD
Hydroxocobalamin—Infusion site reaction—Docetaxel—skin cancer	0.0147	0.0319	CcSEcCtD
Hydroxocobalamin—CUBN—epithelium—skin cancer	0.0122	0.042	CbGeAlD
Hydroxocobalamin—MUT—nipple—skin cancer	0.0115	0.0397	CbGeAlD
Hydroxocobalamin—MUT—neck—skin cancer	0.0114	0.0393	CbGeAlD
Hydroxocobalamin—MMACHC—head—skin cancer	0.0109	0.0376	CbGeAlD
Hydroxocobalamin—Folliculitis—Vemurafenib—skin cancer	0.0107	0.0231	CcSEcCtD
Hydroxocobalamin—TCN2—connective tissue—skin cancer	0.0104	0.0358	CbGeAlD
Hydroxocobalamin—MTRR—nipple—skin cancer	0.0103	0.0357	CbGeAlD
Hydroxocobalamin—TCN1—mammalian vulva—skin cancer	0.00949	0.0328	CbGeAlD
Hydroxocobalamin—Folliculitis—Imiquimod—skin cancer	0.00909	0.0197	CcSEcCtD
Hydroxocobalamin—CUBN—female reproductive system—skin cancer	0.00903	0.0312	CbGeAlD
Hydroxocobalamin—MTR—nipple—skin cancer	0.009	0.0311	CbGeAlD
Hydroxocobalamin—MUT—connective tissue—skin cancer	0.00814	0.0282	CbGeAlD
Hydroxocobalamin—MMAB—female reproductive system—skin cancer	0.00801	0.0277	CbGeAlD
Hydroxocobalamin—Hyponatraemia—Vismodegib—skin cancer	0.0079	0.0171	CcSEcCtD
Hydroxocobalamin—CASP9—lymphoid tissue—skin cancer	0.00776	0.0268	CbGeAlD
Hydroxocobalamin—TCN2—lymphoid tissue—skin cancer	0.00757	0.0262	CbGeAlD
Hydroxocobalamin—CASP9—female reproductive system—skin cancer	0.00748	0.0259	CbGeAlD
Hydroxocobalamin—MTRR—connective tissue—skin cancer	0.00732	0.0253	CbGeAlD
Hydroxocobalamin—TCN2—female reproductive system—skin cancer	0.0073	0.0253	CbGeAlD
Hydroxocobalamin—Feeling hot—Imiquimod—skin cancer	0.00728	0.0158	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Vismodegib—skin cancer	0.00716	0.0155	CcSEcCtD
Hydroxocobalamin—MMAA—head—skin cancer	0.00713	0.0247	CbGeAlD
Hydroxocobalamin—TCN1—head—skin cancer	0.00679	0.0235	CbGeAlD
Hydroxocobalamin—MUT—mammalian vulva—skin cancer	0.0067	0.0232	CbGeAlD
Hydroxocobalamin—MMAB—head—skin cancer	0.00669	0.0231	CbGeAlD
Hydroxocobalamin—MTR—connective tissue—skin cancer	0.00638	0.0221	CbGeAlD
Hydroxocobalamin—AMN—lymph node—skin cancer	0.00627	0.0217	CbGeAlD
Hydroxocobalamin—CASP9—head—skin cancer	0.00625	0.0216	CbGeAlD
Hydroxocobalamin—TCN2—head—skin cancer	0.0061	0.0211	CbGeAlD
Hydroxocobalamin—MTRR—mammalian vulva—skin cancer	0.00602	0.0208	CbGeAlD
Hydroxocobalamin—Folliculitis—Dactinomycin—skin cancer	0.00602	0.013	CcSEcCtD
Hydroxocobalamin—Bullous eruption—Docetaxel—skin cancer	0.00576	0.0125	CcSEcCtD
Hydroxocobalamin—MUT—female reproductive system—skin cancer	0.00574	0.0199	CbGeAlD
Hydroxocobalamin—CUBN—lymph node—skin cancer	0.00528	0.0183	CbGeAlD
Hydroxocobalamin—MTR—mammalian vulva—skin cancer	0.00525	0.0182	CbGeAlD
Hydroxocobalamin—MTRR—female reproductive system—skin cancer	0.00516	0.0178	CbGeAlD
Hydroxocobalamin—Pulmonary oedema—Imiquimod—skin cancer	0.00509	0.011	CcSEcCtD
Hydroxocobalamin—MMAA—lymph node—skin cancer	0.00499	0.0173	CbGeAlD
Hydroxocobalamin—Lung disorder—Temozolomide—skin cancer	0.00484	0.0105	CcSEcCtD
Hydroxocobalamin—MUT—head—skin cancer	0.0048	0.0166	CbGeAlD
Hydroxocobalamin—Swelling—Imiquimod—skin cancer	0.0047	0.0102	CcSEcCtD
Hydroxocobalamin—MMAB—lymph node—skin cancer	0.00468	0.0162	CbGeAlD
Hydroxocobalamin—Extravasation—Bleomycin—skin cancer	0.00465	0.0101	CcSEcCtD
Hydroxocobalamin—Eczema—Imiquimod—skin cancer	0.00462	0.00999	CcSEcCtD
Hydroxocobalamin—MTR—female reproductive system—skin cancer	0.0045	0.0156	CbGeAlD
Hydroxocobalamin—CASP9—lymph node—skin cancer	0.00438	0.0151	CbGeAlD
Hydroxocobalamin—Memory impairment—Temozolomide—skin cancer	0.00436	0.00944	CcSEcCtD
Hydroxocobalamin—Extravasation—Dactinomycin—skin cancer	0.00434	0.00939	CcSEcCtD
Hydroxocobalamin—MTRR—head—skin cancer	0.00431	0.0149	CbGeAlD
Hydroxocobalamin—TCN2—lymph node—skin cancer	0.00427	0.0148	CbGeAlD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00401	0.00868	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Vismodegib—skin cancer	0.00379	0.00821	CcSEcCtD
Hydroxocobalamin—MTR—head—skin cancer	0.00376	0.013	CbGeAlD
Hydroxocobalamin—Skin disorder—Vismodegib—skin cancer	0.00376	0.00813	CcSEcCtD
Hydroxocobalamin—Extravasation—Fluorouracil—skin cancer	0.00362	0.00783	CcSEcCtD
Hydroxocobalamin—Phlebitis—Bleomycin—skin cancer	0.00342	0.0074	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Vismodegib—skin cancer	0.00341	0.00737	CcSEcCtD
Hydroxocobalamin—Redness—Docetaxel—skin cancer	0.00337	0.0073	CcSEcCtD
Hydroxocobalamin—MUT—lymph node—skin cancer	0.00336	0.0116	CbGeAlD
Hydroxocobalamin—Gastrointestinal disorder—Vismodegib—skin cancer	0.00334	0.00723	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Vemurafenib—skin cancer	0.00331	0.00717	CcSEcCtD
Hydroxocobalamin—Pain—Vismodegib—skin cancer	0.00331	0.00716	CcSEcCtD
Hydroxocobalamin—Phlebitis—Dactinomycin—skin cancer	0.00319	0.0069	CcSEcCtD
Hydroxocobalamin—Eye disorder—Vemurafenib—skin cancer	0.00314	0.00681	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Vemurafenib—skin cancer	0.00312	0.00676	CcSEcCtD
Hydroxocobalamin—Angiopathy—Vemurafenib—skin cancer	0.00305	0.00661	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Vemurafenib—skin cancer	0.00303	0.00656	CcSEcCtD
Hydroxocobalamin—Chills—Vemurafenib—skin cancer	0.00302	0.00653	CcSEcCtD
Hydroxocobalamin—MTRR—lymph node—skin cancer	0.00302	0.0104	CbGeAlD
Hydroxocobalamin—Pleural effusion—Docetaxel—skin cancer	0.00297	0.00644	CcSEcCtD
Hydroxocobalamin—Erythema—Vemurafenib—skin cancer	0.00293	0.00634	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Imiquimod—skin cancer	0.00283	0.00613	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Imiquimod—skin cancer	0.00281	0.00609	CcSEcCtD
Hydroxocobalamin—Pruritus—Vismodegib—skin cancer	0.00274	0.00593	CcSEcCtD
Hydroxocobalamin—Eye disorder—Imiquimod—skin cancer	0.00268	0.0058	CcSEcCtD
Hydroxocobalamin—Hot flush—Temozolomide—skin cancer	0.00266	0.00575	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Vismodegib—skin cancer	0.00265	0.00573	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Temozolomide—skin cancer	0.00263	0.0057	CcSEcCtD
Hydroxocobalamin—MTR—lymph node—skin cancer	0.00263	0.00911	CbGeAlD
Hydroxocobalamin—Extravasation—Docetaxel—skin cancer	0.00261	0.00565	CcSEcCtD
Hydroxocobalamin—Angiopathy—Imiquimod—skin cancer	0.0026	0.00563	CcSEcCtD
Hydroxocobalamin—Swelling—Fluorouracil—skin cancer	0.0026	0.00562	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Imiquimod—skin cancer	0.00259	0.00561	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Imiquimod—skin cancer	0.00259	0.0056	CcSEcCtD
Hydroxocobalamin—Chills—Imiquimod—skin cancer	0.00257	0.00557	CcSEcCtD
Hydroxocobalamin—Chest discomfort—Docetaxel—skin cancer	0.00257	0.00557	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Imiquimod—skin cancer	0.00256	0.00555	CcSEcCtD
Hydroxocobalamin—Mental disorder—Imiquimod—skin cancer	0.00251	0.00544	CcSEcCtD
Hydroxocobalamin—Erythema—Imiquimod—skin cancer	0.0025	0.00541	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00248	0.00536	CcSEcCtD
Hydroxocobalamin—Rash—Vismodegib—skin cancer	0.00244	0.00528	CcSEcCtD
Hydroxocobalamin—Dermatitis—Vismodegib—skin cancer	0.00244	0.00528	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Fluorouracil—skin cancer	0.0024	0.00519	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Vemurafenib—skin cancer	0.00239	0.00517	CcSEcCtD
Hydroxocobalamin—Dysphagia—Dactinomycin—skin cancer	0.00238	0.00514	CcSEcCtD
Hydroxocobalamin—Infection—Vemurafenib—skin cancer	0.00237	0.00514	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Vemurafenib—skin cancer	0.00234	0.00507	CcSEcCtD
Hydroxocobalamin—Skin disorder—Vemurafenib—skin cancer	0.00232	0.00503	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Imiquimod—skin cancer	0.00232	0.00502	CcSEcCtD
Hydroxocobalamin—Nausea—Vismodegib—skin cancer	0.0023	0.00497	CcSEcCtD
Hydroxocobalamin—Agitation—Imiquimod—skin cancer	0.0023	0.00497	CcSEcCtD
Hydroxocobalamin—Angioedema—Imiquimod—skin cancer	0.00228	0.00494	CcSEcCtD
Hydroxocobalamin—Blood pressure increased—Docetaxel—skin cancer	0.00228	0.00493	CcSEcCtD
Hydroxocobalamin—Injection site reaction—Docetaxel—skin cancer	0.00226	0.0049	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Temozolomide—skin cancer	0.00226	0.0049	CcSEcCtD
Hydroxocobalamin—Malaise—Imiquimod—skin cancer	0.00225	0.00488	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Fluorouracil—skin cancer	0.00218	0.00471	CcSEcCtD
Hydroxocobalamin—Dysphagia—Temozolomide—skin cancer	0.00215	0.00465	CcSEcCtD
Hydroxocobalamin—Chest pain—Imiquimod—skin cancer	0.00213	0.0046	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00211	0.00457	CcSEcCtD
Hydroxocobalamin—Discomfort—Imiquimod—skin cancer	0.0021	0.00455	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00206	0.00447	CcSEcCtD
Hydroxocobalamin—Oedema—Imiquimod—skin cancer	0.00204	0.00441	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Docetaxel—skin cancer	0.00203	0.00439	CcSEcCtD
Hydroxocobalamin—Infection—Imiquimod—skin cancer	0.00203	0.00438	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Imiquimod—skin cancer	0.002	0.00433	CcSEcCtD
Hydroxocobalamin—Tachycardia—Imiquimod—skin cancer	0.00199	0.00431	CcSEcCtD
Hydroxocobalamin—Skin disorder—Imiquimod—skin cancer	0.00198	0.00429	CcSEcCtD
Hydroxocobalamin—Dysphagia—Fluorouracil—skin cancer	0.00198	0.00428	CcSEcCtD
Hydroxocobalamin—Phlebitis—Docetaxel—skin cancer	0.00192	0.00415	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Vemurafenib—skin cancer	0.00189	0.00409	CcSEcCtD
Hydroxocobalamin—Swelling—Docetaxel—skin cancer	0.00187	0.00406	CcSEcCtD
Hydroxocobalamin—Chills—Bleomycin—skin cancer	0.00183	0.00396	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Docetaxel—skin cancer	0.00182	0.00395	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Imiquimod—skin cancer	0.00182	0.00393	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Imiquimod—skin cancer	0.00179	0.00388	CcSEcCtD
Hydroxocobalamin—Erythema—Bleomycin—skin cancer	0.00177	0.00384	CcSEcCtD
Hydroxocobalamin—Hot flush—Docetaxel—skin cancer	0.00177	0.00382	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Vemurafenib—skin cancer	0.00176	0.00381	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Imiquimod—skin cancer	0.00176	0.00381	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Docetaxel—skin cancer	0.00175	0.00379	CcSEcCtD
Hydroxocobalamin—Pain—Imiquimod—skin cancer	0.00174	0.00377	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Docetaxel—skin cancer	0.00173	0.00374	CcSEcCtD
Hydroxocobalamin—Chills—Dactinomycin—skin cancer	0.00171	0.00369	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Temozolomide—skin cancer	0.0017	0.00368	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Temozolomide—skin cancer	0.00169	0.00367	CcSEcCtD
Hydroxocobalamin—Pruritus—Vemurafenib—skin cancer	0.00169	0.00366	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Temozolomide—skin cancer	0.00169	0.00365	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Imiquimod—skin cancer	0.00168	0.00364	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Docetaxel—skin cancer	0.00166	0.00359	CcSEcCtD
Hydroxocobalamin—Erythema—Dactinomycin—skin cancer	0.00165	0.00358	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Bleomycin—skin cancer	0.00165	0.00356	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Vemurafenib—skin cancer	0.00164	0.00354	CcSEcCtD
Hydroxocobalamin—Urticaria—Imiquimod—skin cancer	0.00162	0.00351	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Imiquimod—skin cancer	0.00161	0.00349	CcSEcCtD
Hydroxocobalamin—Eye disorder—Temozolomide—skin cancer	0.00161	0.00348	CcSEcCtD
Hydroxocobalamin—Malaise—Bleomycin—skin cancer	0.0016	0.00346	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Temozolomide—skin cancer	0.0016	0.00345	CcSEcCtD
Hydroxocobalamin—Dizziness—Vemurafenib—skin cancer	0.00158	0.00342	CcSEcCtD
Hydroxocobalamin—Angiopathy—Temozolomide—skin cancer	0.00156	0.00338	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Temozolomide—skin cancer	0.00155	0.00336	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Temozolomide—skin cancer	0.00155	0.00335	CcSEcCtD
Hydroxocobalamin—Chills—Temozolomide—skin cancer	0.00154	0.00334	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Dactinomycin—skin cancer	0.00154	0.00332	CcSEcCtD
Hydroxocobalamin—Chest pain—Bleomycin—skin cancer	0.00151	0.00327	CcSEcCtD
Hydroxocobalamin—Rash—Vemurafenib—skin cancer	0.00151	0.00326	CcSEcCtD
Hydroxocobalamin—Mental disorder—Temozolomide—skin cancer	0.00151	0.00326	CcSEcCtD
Hydroxocobalamin—Dermatitis—Vemurafenib—skin cancer	0.00151	0.00326	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Imiquimod—skin cancer	0.0015	0.00325	CcSEcCtD
Hydroxocobalamin—Headache—Vemurafenib—skin cancer	0.0015	0.00324	CcSEcCtD
Hydroxocobalamin—Erythema—Temozolomide—skin cancer	0.0015	0.00324	CcSEcCtD
Hydroxocobalamin—Discomfort—Bleomycin—skin cancer	0.00149	0.00323	CcSEcCtD
Hydroxocobalamin—Malaise—Dactinomycin—skin cancer	0.00149	0.00323	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Bleomycin—skin cancer	0.00145	0.00313	CcSEcCtD
Hydroxocobalamin—Oedema—Bleomycin—skin cancer	0.00145	0.00313	CcSEcCtD
Hydroxocobalamin—Pruritus—Imiquimod—skin cancer	0.00144	0.00312	CcSEcCtD
Hydroxocobalamin—Infection—Bleomycin—skin cancer	0.00144	0.00311	CcSEcCtD
Hydroxocobalamin—Dysphagia—Docetaxel—skin cancer	0.00143	0.00309	CcSEcCtD
Hydroxocobalamin—Nausea—Vemurafenib—skin cancer	0.00142	0.00307	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Fluorouracil—skin cancer	0.00142	0.00306	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Imiquimod—skin cancer	0.00139	0.00302	CcSEcCtD
Hydroxocobalamin—Discomfort—Dactinomycin—skin cancer	0.00139	0.00301	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Temozolomide—skin cancer	0.00139	0.00301	CcSEcCtD
Hydroxocobalamin—Erythema—Fluorouracil—skin cancer	0.00138	0.00299	CcSEcCtD
Hydroxocobalamin—Agitation—Temozolomide—skin cancer	0.00138	0.00298	CcSEcCtD
Hydroxocobalamin—Angioedema—Temozolomide—skin cancer	0.00137	0.00296	CcSEcCtD
Hydroxocobalamin—Oedema—Dactinomycin—skin cancer	0.00135	0.00292	CcSEcCtD
Hydroxocobalamin—Malaise—Temozolomide—skin cancer	0.00135	0.00292	CcSEcCtD
Hydroxocobalamin—Dizziness—Imiquimod—skin cancer	0.00135	0.00292	CcSEcCtD
Hydroxocobalamin—Infection—Dactinomycin—skin cancer	0.00134	0.0029	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Bleomycin—skin cancer	0.00129	0.00279	CcSEcCtD
Hydroxocobalamin—Rash—Imiquimod—skin cancer	0.00129	0.00278	CcSEcCtD
Hydroxocobalamin—Dermatitis—Imiquimod—skin cancer	0.00128	0.00278	CcSEcCtD
Hydroxocobalamin—Headache—Imiquimod—skin cancer	0.00128	0.00276	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00127	0.00274	CcSEcCtD
Hydroxocobalamin—Discomfort—Temozolomide—skin cancer	0.00126	0.00273	CcSEcCtD
Hydroxocobalamin—Pain—Bleomycin—skin cancer	0.00124	0.00268	CcSEcCtD
Hydroxocobalamin—Oedema—Temozolomide—skin cancer	0.00122	0.00264	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Temozolomide—skin cancer	0.00122	0.00264	CcSEcCtD
Hydroxocobalamin—Infection—Temozolomide—skin cancer	0.00121	0.00263	CcSEcCtD
Hydroxocobalamin—Nausea—Imiquimod—skin cancer	0.00121	0.00262	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Temozolomide—skin cancer	0.0012	0.00259	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Bleomycin—skin cancer	0.00119	0.00258	CcSEcCtD
Hydroxocobalamin—Skin disorder—Temozolomide—skin cancer	0.00119	0.00257	CcSEcCtD
Hydroxocobalamin—Chest pain—Fluorouracil—skin cancer	0.00117	0.00254	CcSEcCtD
Hydroxocobalamin—Discomfort—Fluorouracil—skin cancer	0.00116	0.00251	CcSEcCtD
Hydroxocobalamin—Pain—Dactinomycin—skin cancer	0.00115	0.0025	CcSEcCtD
Hydroxocobalamin—Urticaria—Bleomycin—skin cancer	0.00115	0.00249	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Bleomycin—skin cancer	0.00114	0.00248	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Docetaxel—skin cancer	0.00113	0.00244	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Docetaxel—skin cancer	0.00113	0.00244	CcSEcCtD
Hydroxocobalamin—Oedema—Fluorouracil—skin cancer	0.00113	0.00244	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Fluorouracil—skin cancer	0.00113	0.00244	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Docetaxel—skin cancer	0.00112	0.00243	CcSEcCtD
Hydroxocobalamin—Infection—Fluorouracil—skin cancer	0.00112	0.00242	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Dactinomycin—skin cancer	0.00111	0.00241	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Fluorouracil—skin cancer	0.0011	0.00239	CcSEcCtD
Hydroxocobalamin—Tachycardia—Fluorouracil—skin cancer	0.0011	0.00238	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Temozolomide—skin cancer	0.00109	0.00236	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Temozolomide—skin cancer	0.00108	0.00233	CcSEcCtD
Hydroxocobalamin—Eye disorder—Docetaxel—skin cancer	0.00107	0.00231	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Dactinomycin—skin cancer	0.00107	0.00231	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Bleomycin—skin cancer	0.00107	0.00231	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Docetaxel—skin cancer	0.00106	0.0023	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Temozolomide—skin cancer	0.00105	0.00228	CcSEcCtD
Hydroxocobalamin—Pain—Temozolomide—skin cancer	0.00104	0.00226	CcSEcCtD
Hydroxocobalamin—Angiopathy—Docetaxel—skin cancer	0.00104	0.00225	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Docetaxel—skin cancer	0.00103	0.00224	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Docetaxel—skin cancer	0.00103	0.00223	CcSEcCtD
Hydroxocobalamin—Chills—Docetaxel—skin cancer	0.00103	0.00222	CcSEcCtD
Hydroxocobalamin—Pruritus—Bleomycin—skin cancer	0.00102	0.00222	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Docetaxel—skin cancer	0.00102	0.00221	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Temozolomide—skin cancer	0.00101	0.00218	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Fluorouracil—skin cancer	0.001	0.00217	CcSEcCtD
Hydroxocobalamin—Mental disorder—Docetaxel—skin cancer	0.001	0.00217	CcSEcCtD
Hydroxocobalamin—Erythema—Docetaxel—skin cancer	0.000995	0.00215	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Dactinomycin—skin cancer	0.000995	0.00215	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Fluorouracil—skin cancer	0.000991	0.00214	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000972	0.0021	CcSEcCtD
Hydroxocobalamin—Urticaria—Temozolomide—skin cancer	0.00097	0.0021	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Temozolomide—skin cancer	0.000966	0.00209	CcSEcCtD
Hydroxocobalamin—Pain—Fluorouracil—skin cancer	0.000962	0.00208	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Fluorouracil—skin cancer	0.000928	0.00201	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Dactinomycin—skin cancer	0.000924	0.002	CcSEcCtD
Hydroxocobalamin—Rash—Bleomycin—skin cancer	0.000913	0.00198	CcSEcCtD
Hydroxocobalamin—Dermatitis—Bleomycin—skin cancer	0.000912	0.00197	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Temozolomide—skin cancer	0.0009	0.00195	CcSEcCtD
Hydroxocobalamin—Urticaria—Fluorouracil—skin cancer	0.000894	0.00194	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Fluorouracil—skin cancer	0.00089	0.00193	CcSEcCtD
Hydroxocobalamin—Pruritus—Temozolomide—skin cancer	0.000864	0.00187	CcSEcCtD
Hydroxocobalamin—Nausea—Bleomycin—skin cancer	0.00086	0.00186	CcSEcCtD
Hydroxocobalamin—Rash—Dactinomycin—skin cancer	0.000852	0.00184	CcSEcCtD
Hydroxocobalamin—Chest pain—Docetaxel—skin cancer	0.000847	0.00183	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000842	0.00182	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Temozolomide—skin cancer	0.000836	0.00181	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Fluorouracil—skin cancer	0.000829	0.0018	CcSEcCtD
Hydroxocobalamin—Oedema—Docetaxel—skin cancer	0.000812	0.00176	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Docetaxel—skin cancer	0.000812	0.00176	CcSEcCtD
Hydroxocobalamin—Dizziness—Temozolomide—skin cancer	0.000808	0.00175	CcSEcCtD
Hydroxocobalamin—Infection—Docetaxel—skin cancer	0.000807	0.00175	CcSEcCtD
Hydroxocobalamin—Nausea—Dactinomycin—skin cancer	0.000802	0.00174	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Docetaxel—skin cancer	0.000797	0.00172	CcSEcCtD
Hydroxocobalamin—Pruritus—Fluorouracil—skin cancer	0.000796	0.00172	CcSEcCtD
Hydroxocobalamin—Tachycardia—Docetaxel—skin cancer	0.000793	0.00172	CcSEcCtD
Hydroxocobalamin—Skin disorder—Docetaxel—skin cancer	0.000789	0.00171	CcSEcCtD
Hydroxocobalamin—Rash—Temozolomide—skin cancer	0.00077	0.00167	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Fluorouracil—skin cancer	0.00077	0.00167	CcSEcCtD
Hydroxocobalamin—Dermatitis—Temozolomide—skin cancer	0.00077	0.00167	CcSEcCtD
Hydroxocobalamin—Headache—Temozolomide—skin cancer	0.000765	0.00166	CcSEcCtD
Hydroxocobalamin—Dizziness—Fluorouracil—skin cancer	0.000744	0.00161	CcSEcCtD
Hydroxocobalamin—Nausea—Temozolomide—skin cancer	0.000726	0.00157	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Docetaxel—skin cancer	0.000724	0.00157	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Docetaxel—skin cancer	0.000715	0.00155	CcSEcCtD
Hydroxocobalamin—Rash—Fluorouracil—skin cancer	0.00071	0.00154	CcSEcCtD
Hydroxocobalamin—Dermatitis—Fluorouracil—skin cancer	0.000709	0.00153	CcSEcCtD
Hydroxocobalamin—Headache—Fluorouracil—skin cancer	0.000705	0.00153	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Docetaxel—skin cancer	0.000701	0.00152	CcSEcCtD
Hydroxocobalamin—Pain—Docetaxel—skin cancer	0.000695	0.0015	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Docetaxel—skin cancer	0.000669	0.00145	CcSEcCtD
Hydroxocobalamin—Nausea—Fluorouracil—skin cancer	0.000669	0.00145	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Docetaxel—skin cancer	0.000642	0.00139	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Docetaxel—skin cancer	0.000599	0.0013	CcSEcCtD
Hydroxocobalamin—Pruritus—Docetaxel—skin cancer	0.000575	0.00124	CcSEcCtD
Hydroxocobalamin—MTR—Disease—CSPG4—skin cancer	0.000564	0.00227	CbGpPWpGaD
Hydroxocobalamin—Diarrhoea—Docetaxel—skin cancer	0.000556	0.0012	CcSEcCtD
Hydroxocobalamin—CASP9—Alzheimers Disease—TP53—skin cancer	0.000546	0.00219	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—ENO2—skin cancer	0.000545	0.00219	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—ENO2—skin cancer	0.000545	0.00219	CbGpPWpGaD
Hydroxocobalamin—CASP9—TNF alpha Signaling Pathway—KRAS—skin cancer	0.000544	0.00218	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Docetaxel—skin cancer	0.000537	0.00116	CcSEcCtD
Hydroxocobalamin—AMN—Disease—FOXO4—skin cancer	0.00053	0.00213	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—FOXO4—skin cancer	0.00053	0.00213	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—BRAF—skin cancer	0.000528	0.00212	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TP53—skin cancer	0.00052	0.00209	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—ENO2—skin cancer	0.00052	0.00209	CbGpPWpGaD
Hydroxocobalamin—Rash—Docetaxel—skin cancer	0.000512	0.00111	CcSEcCtD
Hydroxocobalamin—Dermatitis—Docetaxel—skin cancer	0.000512	0.00111	CcSEcCtD
Hydroxocobalamin—Headache—Docetaxel—skin cancer	0.000509	0.0011	CcSEcCtD
Hydroxocobalamin—MUT—Disease—FOXO4—skin cancer	0.000506	0.00203	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—ERCC2—skin cancer	0.000499	0.002	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—TLR7—skin cancer	0.000495	0.00199	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis Modulation and Signaling—TP53—skin cancer	0.000488	0.00196	CbGpPWpGaD
Hydroxocobalamin—Nausea—Docetaxel—skin cancer	0.000483	0.00104	CcSEcCtD
Hydroxocobalamin—CUBN—Metabolism—ENO2—skin cancer	0.00048	0.00193	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CSPG4—skin cancer	0.000472	0.0019	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—ENO2—skin cancer	0.00047	0.00189	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—SHH—skin cancer	0.00047	0.00189	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—TERT—skin cancer	0.000467	0.00188	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—FOXO4—skin cancer	0.000467	0.00187	CbGpPWpGaD
Hydroxocobalamin—CASP9—TNF alpha Signaling Pathway—HRAS—skin cancer	0.000462	0.00186	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—ERCC2—skin cancer	0.000456	0.00183	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—ERCC2—skin cancer	0.000456	0.00183	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	0.000453	0.00182	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—NRAS—skin cancer	0.000449	0.0018	CbGpPWpGaD
Hydroxocobalamin—CASP9—TNF alpha Signaling Pathway—IL6—skin cancer	0.000442	0.00178	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—FOXO4—skin cancer	0.000437	0.00176	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—NRAS—skin cancer	0.00043	0.00173	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—TERT—skin cancer	0.000427	0.00172	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—TERT—skin cancer	0.000427	0.00172	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	0.000426	0.00171	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	0.000426	0.00171	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CSPG4—skin cancer	0.000425	0.00171	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—ERCC2—skin cancer	0.000424	0.0017	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—NRAS—skin cancer	0.000423	0.0017	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—FOXO4—skin cancer	0.00042	0.00169	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—ERCC2—skin cancer	0.000417	0.00168	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	0.000406	0.00163	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—BRAF—skin cancer	0.000406	0.00163	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—NRAS—skin cancer	0.000404	0.00162	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—NRAS—skin cancer	0.000402	0.00161	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—NRAS—skin cancer	0.0004	0.00161	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—NRAS—skin cancer	0.000398	0.0016	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—TERT—skin cancer	0.000397	0.0016	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—ENO2—skin cancer	0.000394	0.00158	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTCH2—skin cancer	0.000392	0.00158	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—NRAS—skin cancer	0.000392	0.00157	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—NRAS—skin cancer	0.00039	0.00157	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—KRAS—skin cancer	0.000386	0.00155	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—FOXO4—skin cancer	0.000383	0.00154	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—SHH—skin cancer	0.000383	0.00154	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—ENO2—skin cancer	0.000383	0.00154	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—ERCC2—skin cancer	0.000382	0.00153	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—ERCC2—skin cancer	0.000382	0.00153	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—ERCC2—skin cancer	0.000378	0.00152	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—ERCC2—skin cancer	0.000378	0.00152	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	0.000375	0.00151	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—NRAS—skin cancer	0.000374	0.0015	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—NRAS—skin cancer	0.000374	0.0015	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—NRAS—skin cancer	0.000374	0.0015	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—NRAS—skin cancer	0.000371	0.00149	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—BRAF—skin cancer	0.00037	0.00149	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—KRAS—skin cancer	0.00037	0.00149	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—NRAS—skin cancer	0.000368	0.00148	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—NRAS—skin cancer	0.000366	0.00147	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—KRAS—skin cancer	0.000366	0.00147	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—KRAS—skin cancer	0.000364	0.00146	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—ERCC2—skin cancer	0.00036	0.00145	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—ERCC2—skin cancer	0.000355	0.00143	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—TERT—skin cancer	0.000354	0.00142	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—TERT—skin cancer	0.000354	0.00142	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—KRAS—skin cancer	0.000348	0.0014	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—NRAS—skin cancer	0.000346	0.00139	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—KRAS—skin cancer	0.000346	0.00139	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—KRAS—skin cancer	0.000344	0.00138	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—KRAS—skin cancer	0.000342	0.00138	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—BRAF—skin cancer	0.000338	0.00136	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—BRAF—skin cancer	0.000338	0.00136	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—TERT—skin cancer	0.000338	0.00136	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—KRAS—skin cancer	0.000338	0.00136	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—KRAS—skin cancer	0.000336	0.00135	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—ERCC2—skin cancer	0.000333	0.00134	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—NRAS—skin cancer	0.000332	0.00133	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—HRAS—skin cancer	0.000328	0.00132	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—TP53—skin cancer	0.000325	0.00131	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—KRAS—skin cancer	0.000322	0.00129	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—KRAS—skin cancer	0.000322	0.00129	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—KRAS—skin cancer	0.000322	0.00129	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ENO2—skin cancer	0.000321	0.00129	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—KRAS—skin cancer	0.000319	0.00128	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TP53—skin cancer	0.000318	0.00128	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—KRAS—skin cancer	0.000316	0.00127	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—ERCC2—skin cancer	0.000316	0.00127	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—ERCC2—skin cancer	0.000316	0.00127	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—KRAS—skin cancer	0.000315	0.00127	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—BRAF—skin cancer	0.000315	0.00126	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—IL6—skin cancer	0.000314	0.00126	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—HRAS—skin cancer	0.000314	0.00126	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—FOXO4—skin cancer	0.000312	0.00126	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—TERT—skin cancer	0.000312	0.00125	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—HRAS—skin cancer	0.000309	0.00124	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	0.000303	0.00122	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—ERCC2—skin cancer	0.000302	0.00121	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—IL6—skin cancer	0.000301	0.00121	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—PTGS2—skin cancer	0.000299	0.0012	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—TP53—skin cancer	0.000299	0.0012	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—KRAS—skin cancer	0.000298	0.0012	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GLI2—skin cancer	0.000297	0.00119	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—IL6—skin cancer	0.000296	0.00119	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—HRAS—skin cancer	0.000295	0.00119	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—HRAS—skin cancer	0.000294	0.00118	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—HRAS—skin cancer	0.000292	0.00117	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—HRAS—skin cancer	0.000291	0.00117	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SHH—skin cancer	0.000289	0.00116	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ENO2—skin cancer	0.000289	0.00116	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—HRAS—skin cancer	0.000287	0.00115	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—KRAS—skin cancer	0.000285	0.00115	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MC1R—skin cancer	0.000284	0.00114	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—IL6—skin cancer	0.000283	0.00114	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—IL6—skin cancer	0.000281	0.00113	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—BRAF—skin cancer	0.00028	0.00113	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—BRAF—skin cancer	0.00028	0.00113	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—IL6—skin cancer	0.00028	0.00112	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GLI1—skin cancer	0.00028	0.00112	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—IL6—skin cancer	0.000279	0.00112	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—ERCC2—skin cancer	0.000279	0.00112	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—HRAS—skin cancer	0.000274	0.0011	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	0.000274	0.0011	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—HRAS—skin cancer	0.000274	0.0011	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—PTGS2—skin cancer	0.000273	0.0011	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—PTGS2—skin cancer	0.000273	0.0011	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—ERCC2—skin cancer	0.000273	0.0011	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—HRAS—skin cancer	0.000271	0.00109	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	0.000269	0.00108	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—HRAS—skin cancer	0.000269	0.00108	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—HRAS—skin cancer	0.000268	0.00108	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—BRAF—skin cancer	0.000268	0.00107	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SUFU—skin cancer	0.000265	0.00106	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—IL6—skin cancer	0.000262	0.00105	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	0.000262	0.00105	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—IL6—skin cancer	0.000262	0.00105	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—IL6—skin cancer	0.00026	0.00104	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—IL6—skin cancer	0.000257	0.00103	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—IL6—skin cancer	0.000256	0.00103	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—TERT—skin cancer	0.000256	0.00103	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—NRAS—skin cancer	0.000255	0.00102	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FOXO4—skin cancer	0.000255	0.00102	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PTGS2—skin cancer	0.000254	0.00102	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—HRAS—skin cancer	0.000253	0.00102	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PTGS2—skin cancer	0.00025	0.00101	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—BRAF—skin cancer	0.000247	0.000992	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	0.000243	0.000974	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—FOXO4—skin cancer	0.000235	0.000945	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—NRAS—skin cancer	0.000233	0.000934	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	0.000232	0.000932	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PTGS2—skin cancer	0.000229	0.00092	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PTGS2—skin cancer	0.000229	0.00092	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—ERCC2—skin cancer	0.000229	0.000919	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PTGS2—skin cancer	0.000227	0.00091	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PTGS2—skin cancer	0.000227	0.00091	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—ERCC2—skin cancer	0.000223	0.000894	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—KRAS—skin cancer	0.000219	0.000881	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PTGS2—skin cancer	0.000216	0.000868	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PTGS2—skin cancer	0.000213	0.000855	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—NRAS—skin cancer	0.000213	0.000854	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—NRAS—skin cancer	0.000213	0.000854	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TERT—skin cancer	0.000209	0.000838	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—BRAF—skin cancer	0.000203	0.000814	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SHH—skin cancer	0.000202	0.000812	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RASA1—skin cancer	0.000201	0.000807	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—KRAS—skin cancer	0.0002	0.000804	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTGS2—skin cancer	0.000199	0.000801	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—NRAS—skin cancer	0.000198	0.000794	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTCH1—skin cancer	0.000192	0.000769	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SMO—skin cancer	0.000192	0.000769	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTGS2—skin cancer	0.00019	0.000762	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTGS2—skin cancer	0.00019	0.000762	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—HRAS—skin cancer	0.000187	0.000749	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTGER4—skin cancer	0.000187	0.000749	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ERCC2—skin cancer	0.000186	0.000749	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—KRAS—skin cancer	0.000183	0.000735	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—KRAS—skin cancer	0.000183	0.000735	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTGS2—skin cancer	0.000181	0.000727	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—IL6—skin cancer	0.000179	0.000717	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—NRAS—skin cancer	0.000176	0.000708	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—NRAS—skin cancer	0.000176	0.000708	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—KRAS—skin cancer	0.00017	0.000684	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—HRAS—skin cancer	0.00017	0.000683	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—NRAS—skin cancer	0.000168	0.000675	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ERCC2—skin cancer	0.000168	0.000673	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTGS2—skin cancer	0.000167	0.000671	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—BRAF—skin cancer	0.000165	0.000664	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FOXO4—skin cancer	0.000165	0.000662	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTGS2—skin cancer	0.000164	0.000658	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—IL6—skin cancer	0.000163	0.000654	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TERT—skin cancer	0.000157	0.000631	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—HRAS—skin cancer	0.000156	0.000625	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—HRAS—skin cancer	0.000156	0.000625	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NRAS—skin cancer	0.000155	0.000623	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—KRAS—skin cancer	0.000152	0.000609	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—KRAS—skin cancer	0.000152	0.000609	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—IL6—skin cancer	0.000149	0.000598	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—IL6—skin cancer	0.000149	0.000598	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—NRAS—skin cancer	0.000145	0.000584	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KRAS—skin cancer	0.000145	0.000581	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—HRAS—skin cancer	0.000145	0.000581	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—NRAS—skin cancer	0.00014	0.000561	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—IL6—skin cancer	0.000138	0.000556	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTGS2—skin cancer	0.000137	0.000551	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KRAS—skin cancer	0.000134	0.000536	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTGS2—skin cancer	0.000134	0.000536	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HRAS—skin cancer	0.000129	0.000518	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—HRAS—skin cancer	0.000129	0.000518	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NRAS—skin cancer	0.000127	0.000512	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KRAS—skin cancer	0.000125	0.000503	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—BRAF—skin cancer	0.000124	0.0005	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—IL6—skin cancer	0.000123	0.000496	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—IL6—skin cancer	0.000123	0.000496	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—HRAS—skin cancer	0.000123	0.000494	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—KRAS—skin cancer	0.00012	0.000483	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—IL6—skin cancer	0.000118	0.000473	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—HRAS—skin cancer	0.000114	0.000456	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTGS2—skin cancer	0.000112	0.000449	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TERT—skin cancer	0.00011	0.000442	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KRAS—skin cancer	0.00011	0.000441	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—IL6—skin cancer	0.000109	0.000436	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—HRAS—skin cancer	0.000106	0.000427	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NRAS—skin cancer	0.000104	0.000417	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HRAS—skin cancer	0.000102	0.00041	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—IL6—skin cancer	0.000102	0.000409	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTGS2—skin cancer	0.000101	0.000404	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—HRAS—skin cancer	9.32e-05	0.000374	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KRAS—skin cancer	8.94e-05	0.000359	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—IL6—skin cancer	8.92e-05	0.000358	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—BRAF—skin cancer	8.71e-05	0.00035	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NRAS—skin cancer	8.47e-05	0.00034	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NRAS—skin cancer	7.82e-05	0.000314	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HRAS—skin cancer	7.6e-05	0.000305	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KRAS—skin cancer	7.29e-05	0.000293	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—IL6—skin cancer	7.27e-05	0.000292	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KRAS—skin cancer	6.73e-05	0.00027	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HRAS—skin cancer	6.2e-05	0.000249	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL6—skin cancer	5.93e-05	0.000238	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HRAS—skin cancer	5.72e-05	0.00023	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NRAS—skin cancer	5.48e-05	0.00022	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IL6—skin cancer	5.48e-05	0.00022	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KRAS—skin cancer	4.71e-05	0.000189	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—skin cancer	4.19e-05	0.000168	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HRAS—skin cancer	4.01e-05	0.000161	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL6—skin cancer	3.83e-05	0.000154	CbGpPWpGaD
